SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-543845
Filing Date
2016-04-18
Accepted
2016-04-18 07:00:34
Documents
14
Period of Report
2016-04-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d125278d8k.htm 8-K 12663
2 EX-99.1 d125278dex991.htm EX-99.1 18371
3 GRAPHIC g125278ex99_1s10g1.jpg GRAPHIC 274303
4 GRAPHIC g125278ex99_1s11g1.jpg GRAPHIC 262983
5 GRAPHIC g125278ex99_1s12g1.jpg GRAPHIC 288853
6 GRAPHIC g125278ex99_1s1g1.jpg GRAPHIC 236128
7 GRAPHIC g125278ex99_1s2g1.jpg GRAPHIC 509480
8 GRAPHIC g125278ex99_1s3g1.jpg GRAPHIC 287102
9 GRAPHIC g125278ex99_1s4g1.jpg GRAPHIC 214813
10 GRAPHIC g125278ex99_1s5g1.jpg GRAPHIC 199569
11 GRAPHIC g125278ex99_1s6g1.jpg GRAPHIC 204515
12 GRAPHIC g125278ex99_1s7g1.jpg GRAPHIC 357573
13 GRAPHIC g125278ex99_1s8g1.jpg GRAPHIC 373821
14 GRAPHIC g125278ex99_1s9g1.jpg GRAPHIC 385532
  Complete submission text file 0001193125-16-543845.txt   4984589
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8794
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 161575737
SIC: 8731 Services-Commercial Physical & Biological Research